Clinical Trial Results: Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating antroquinonol in combination with standard of care in first-line metastatic pancreatic cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Neoplasm

Drugs mentioned

• Antroquinonol (antroquinonol)

Snippet

Sponsor: Golden Biotechnology Corporation | Conditions: Pancreatic Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-07-02